379 related articles for article (PubMed ID: 19609076)
1. Chronic COX inhibition reduces diabetes-induced hyperfiltration, proteinuria, and renal pathological markers in 36-week B6-Ins2(Akita) mice.
Nasrallah R; Robertson SJ; Hébert RL
Am J Nephrol; 2009; 30(4):346-53. PubMed ID: 19609076
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib modifies glomerular basement membrane, mesangium and podocytes in OVE26 mice, but ibuprofen is more detrimental.
Nasrallah R; Robertson SJ; Karsh J; Hébert RL
Clin Sci (Lond); 2013 Jun; 124(11):685-94. PubMed ID: 23305077
[TBL] [Abstract][Full Text] [Related]
3. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy.
Tchekneva EE; Rinchik EM; Polosukhina D; Davis LS; Kadkina V; Mohamed Y; Dunn SR; Sharma K; Qi Z; Fogo AB; Breyer MD
J Am Soc Nephrol; 2007 Jan; 18(1):103-12. PubMed ID: 17151334
[TBL] [Abstract][Full Text] [Related]
4. Renal prostaglandin E2 receptor (EP) expression profile is altered in streptozotocin and B6-Ins2Akita type I diabetic mice.
Nasrallah R; Xiong H; Hébert RL
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F278-84. PubMed ID: 16954344
[TBL] [Abstract][Full Text] [Related]
5. Effects of short-term treatment with diclofenac-colestyramine on renal function and urinary prostanoid excretion in patients with type-2 diabetes.
Farker K; Merkel U; Schweer H; Haerting J; Madani SF; Eggers R; Müller UA; Seyberth HW; Hoffmann A
Eur J Clin Pharmacol; 2002 May; 58(2):85-91. PubMed ID: 12012138
[TBL] [Abstract][Full Text] [Related]
6. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
[TBL] [Abstract][Full Text] [Related]
7. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
Jia ZH; Liu ZH; Zheng JM; Zeng CH; Li LS
Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690
[TBL] [Abstract][Full Text] [Related]
8. The COX-2 inhibitor NS-398 causes T-cell developmental disruptions independent of COX-2 enzyme inhibition.
Xu H; Izon DJ; Loftin C; Spain LM
Cell Immunol; 2001 Dec; 214(2):184-93. PubMed ID: 12088417
[TBL] [Abstract][Full Text] [Related]
9. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
10. Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice.
Gurley SB; Mach CL; Stegbauer J; Yang J; Snow KP; Hu A; Meyer TW; Coffman TM
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F788-95. PubMed ID: 20042456
[TBL] [Abstract][Full Text] [Related]
11. Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells.
Andrews J; Djakiew D; Krygier S; Andrews P
Cancer Chemother Pharmacol; 2002 Oct; 50(4):277-84. PubMed ID: 12357301
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.
Tanaka K; Suemasu S; Ishihara T; Tasaka Y; Arai Y; Mizushima T
Eur J Pharmacol; 2009 Jan; 603(1-3):120-32. PubMed ID: 19101538
[TBL] [Abstract][Full Text] [Related]
13. The effect of cyclooxygenase-2 inhibition on renal hemodynamic function in humans with type 1 diabetes.
Cherney DZ; Miller JA; Scholey JW; Bradley TJ; Slorach C; Curtis JR; Dekker MG; Nasrallah R; Hébert RL; Sochett EB
Diabetes; 2008 Mar; 57(3):688-95. PubMed ID: 18083781
[TBL] [Abstract][Full Text] [Related]
14. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice.
Vallon V; Gerasimova M; Rose MA; Masuda T; Satriano J; Mayoux E; Koepsell H; Thomson SC; Rieg T
Am J Physiol Renal Physiol; 2014 Jan; 306(2):F194-204. PubMed ID: 24226524
[TBL] [Abstract][Full Text] [Related]
15. The Ins2Akita mouse as a model of early retinal complications in diabetes.
Barber AJ; Antonetti DA; Kern TS; Reiter CE; Soans RS; Krady JK; Levison SW; Gardner TW; Bronson SK
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2210-8. PubMed ID: 15914643
[TBL] [Abstract][Full Text] [Related]
16. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
17. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.
Liu IM; Tzeng TF; Liou SS; Chang CJ
J Ethnopharmacol; 2009 Jul; 124(2):211-8. PubMed ID: 19397971
[TBL] [Abstract][Full Text] [Related]
18. Assessment of diabetic nephropathy in the Akita mouse.
Chang JH; Gurley SB
Methods Mol Biol; 2012; 933():17-29. PubMed ID: 22893398
[TBL] [Abstract][Full Text] [Related]
19. Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy.
Gao Q; Qin WS; Jia ZH; Zheng JM; Zeng CH; Li LS; Liu ZH
Planta Med; 2010 Jan; 76(1):27-33. PubMed ID: 19639539
[TBL] [Abstract][Full Text] [Related]
20. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
Ninichuk V; Kulkarni O; Clauss S; Anders H-
Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]